Tags: Drug.

Rontalizumab is a humanized monoclonal antibody being developed by Genentech. As of November 2009 it is being investigated in a clinical trial or the treatment of systemic lupus erythematosus.

ATC prefix
none
CAS number
948570-30-7
FDA UNII code
LDO2FIQ61I

Loading...

This page contains content from the copyrighted Wikipedia article "Rontalizumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.